Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With physician-reviewed results, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Key benefits of Atherogenic Coefficient testing

• Flags your cardiovascular risk by comparing harmful to protective cholesterol types.
• Spots early imbalance before plaque buildup or heart disease symptoms appear.
• Guides lipid-lowering treatment decisions alongside your total cholesterol and LDL levels.
• Tracks how well lifestyle changes or medications are rebalancing your cholesterol.
• Clarifies whether borderline cholesterol numbers pose real cardiovascular threat or not.
• Protects long-term heart health by identifying hidden risk in metabolic syndrome.
• Best interpreted with a full lipid panel and your personal risk factors.

What is Atherogenic Coefficient?

The atherogenic coefficient is a calculated ratio that compares "bad" cholesterol to "good" cholesterol in your blood. It divides total cholesterol (or sometimes non-HDL cholesterol) by HDL cholesterol, the protective type that carries cholesterol away from artery walls back to the liver for disposal.

This ratio was developed to capture cardiovascular risk more precisely than looking at total cholesterol alone. A higher coefficient suggests that harmful cholesterol particles outnumber the protective ones, creating conditions that favor plaque buildup inside arteries (atherosclerosis).

A snapshot of cholesterol balance

The coefficient reflects the balance between cholesterol delivery to tissues and cholesterol removal from circulation. When delivery exceeds removal, excess cholesterol can accumulate in artery walls.

Why ratios matter more than absolutes

Absolute cholesterol numbers don't tell the whole story. Someone with moderately elevated total cholesterol but robust HDL may have lower risk than someone with average total cholesterol but very low HDL.

A tool, not a diagnosis

The atherogenic coefficient helps clinicians assess cardiovascular risk patterns. It complements other lipid markers and clinical factors to guide prevention strategies.

Why is Atherogenic Coefficient important?

The atherogenic coefficient estimates your cardiovascular risk by comparing cholesterol that clogs arteries to cholesterol that clears them. It's calculated by dividing total cholesterol minus HDL by HDL itself, revealing how balanced - or imbalanced - your lipid transport system is. Lower values, typically below 3, suggest your body is efficiently removing cholesterol from vessel walls, while higher numbers signal accumulation and inflammation that silently damage your heart and brain.

When your arteries stay clean

Values under 3 reflect a protective lipid profile where HDL cholesterol is abundant enough to shuttle excess cholesterol back to the liver for disposal. This reduces plaque formation in coronary and carotid arteries, lowering stroke and heart attack risk. You're less likely to experience chest pain, claudication, or cognitive decline tied to poor circulation.

When plaque begins to build

Coefficients above 4 or 5 indicate that atherogenic lipoproteins - primarily LDL and VLDL - are overwhelming your reverse transport capacity. Cholesterol deposits thicken artery walls, narrowing blood flow to the heart, kidneys, and extremities. Over time, this drives hypertension, angina, erectile dysfunction in men, and accelerates vascular aging in postmenopausal women who lose estrogen's protective effects.

The long view on vascular health

This ratio integrates multiple lipid signals into one snapshot of endothelial stress and systemic inflammation. It complements standard cholesterol panels by highlighting functional imbalance rather than isolated numbers. Tracking it over years helps predict not just cardiac events but also dementia, peripheral artery disease, and metabolic syndrome progression.

What do my Atherogenic Coefficient results mean?

Low atherogenic coefficient values

Low values usually reflect a favorable lipid profile with high protective HDL cholesterol relative to total cholesterol. This pattern suggests efficient reverse cholesterol transport, where HDL actively removes cholesterol from arterial walls and delivers it to the liver for clearance. A low coefficient typically indicates lower cardiovascular risk and better metabolic health. Women generally have lower values than men due to higher baseline HDL levels, particularly during reproductive years when estrogen supports HDL production.

Optimal atherogenic coefficient range

Being in range suggests balanced cholesterol metabolism with adequate HDL protection relative to total cholesterol burden. Most labs define optimal as a coefficient below 3.0 to 4.0, though cardiovascular risk increases progressively even within the reference range. Lower values within the normal range generally reflect better arterial health and more efficient lipid clearance systems.

High atherogenic coefficient values

High values usually reflect either elevated atherogenic lipids (LDL and VLDL) or insufficient protective HDL, or both. This imbalance indicates increased cholesterol deposition in arterial walls with inadequate reverse transport. Common drivers include insulin resistance, metabolic syndrome, chronic inflammation, and sedentary patterns. Men and postmenopausal women tend toward higher values as protective hormonal influences decline.

Factors that influence interpretation

The coefficient responds to acute illness, which temporarily lowers HDL and raises the ratio. Pregnancy typically improves the ratio in early trimesters before physiologic lipid elevation occurs. Calculation methods vary slightly between labs depending on whether VLDL is measured or estimated.